WaferGen Q1 Revenues Drop on Sluggish SmartChip Equipment Sales | GenomeWeb

NEW YORK (GenomeWeb) – WaferGen Biosystems reported after the close of the market Monday an 18 percent drop in first quarter revenues, primarily due to weak sales of its SmartChip system, though it saw a sharp increase in SmartChip consumables and services.

For the three-month period ended March 31, WaferGen's revenues slipped to $1.1 million from $1.4 million year over year, well off the average analysts' estimate of $2.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.